Physician
Dana-Farber Cancer Institute
I am an early career clinical and translational investigator in the Sarcoma Center at Dana-Farber Cancer Institute (DFCI) and my overarching career goals are to (1) identify novel predictive biomarkers and targets for developing new therapies, (2) evaluate promising preclinical leads in early phase clinical trials with integral biomarkers and embedded correlative studies that provide insight into treatment response and resistance, and (3) incorporate findings from my work into subsequent trials and ultimately clinical practice. I joined DFCI in 2021 and lead trials in our Sarcoma Center and the Center for Cancer Therapeutic Innovation (CCTI), which is DFCI's early phase clinical trial program. I enjoy partnering with specialists from other centers, disciplines, and settings (e.g. lab, informatics) to develop projects that help us better understand sarcoma biology and find new treatments.
